Valuation: Becton, Dickinson and Company

Market Cap 5.06TCr 4.39TCr 4.15TCr 3.76TCr 7.05TCr 4,85400Cr 7.1TCr 49TCr 19TCr 2,46300Cr 19TCr 19TCr 7,85400Cr P/E 2026 *
35.8x
P/E 2027 * 20x
Enterprise Value 6.65TCr 5.76TCr 5.45TCr 4.94TCr 9.26TCr 6,37700Cr 9.33TCr 65TCr 25TCr 3,23500Cr 25TCr 24TCr 10,31800Cr EV / Sales 2026 *
3.45x
EV / Sales 2027 * 3.28x
Free-Float
73.18%
Yield 2026 *
2.11%
Yield 2027 * 2.15%
1 week+0.70%
Current month-1.95%
1 month+0.28%
3 months+25.35%
6 months+13.82%
Current year+20.42%
1 week 151.05
Extreme 151.05
161.5
1 month 151.05
Extreme 151.05
164.75
3 years 114.84
Extreme 114.84280575
199.55
5 years 114.84
Extreme 114.84280575
210.8
10 years 114.84
Extreme 114.84280575
210.8
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.26%+0.70%+23.22%-18.96% 4.98TCr
-1.03%-5.82%-23.70%-0.60% 18TCr
-0.05%-0.45%-0.30%+14.39% 12TCr
-0.90%-2.31%+6.87%+82.66% 6.23TCr
-0.45%-7.52%+5.36%+36.49% 4.85TCr
+1.65%+0.64%-0.49%-29.74% 4.98TCr
+2.09%-1.65%+13.42%-14.87% 3.2TCr
-1.47%-12.24% - - 2.86TCr
+2.76%+7.36%+43.98%-8.27% 2.5TCr
-0.88%-5.52%-13.43%+3.39% 2.16TCr
Average +0.45%-3.58%+6.10%+7.16% 6.29TCr
Weighted average by Cap. +0.53%-3.32%-2.05%+9.36%

Financials

2026 *2027 *
Net sales 1.93TCr 1.67TCr 1.58TCr 1.43TCr 2.68TCr 1,84600Cr 2.7TCr 19TCr 7.24TCr 94TCr 7.23TCr 7.07TCr 2,98700Cr 1.97TCr 1.71TCr 1.61TCr 1.46TCr 2.74TCr 1,88700Cr 2.76TCr 19TCr 7.4TCr 96TCr 7.4TCr 7.23TCr 3,05400Cr
Net income 143.66Cr 124.46Cr 117.61Cr 106.61Cr 200Cr 14TCr 201.46Cr 1.4TCr 540.23Cr 6.99TCr 539.6Cr 527.65Cr 22TCr 233.95Cr 202.68Cr 191.53Cr 173.61Cr 325.69Cr 22TCr 328.07Cr 2.28TCr 879.75Cr 11TCr 878.72Cr 859.25Cr 36TCr
Net Debt 1.59TCr 1.38TCr 1.3TCr 1.18TCr 2.21TCr 1,52300Cr 2.23TCr 16TCr 5.97TCr 77TCr 5.97TCr 5.83TCr 2,46400Cr 1.4TCr 1.21TCr 1.14TCr 1.04TCr 1.94TCr 1,33700Cr 1.96TCr 14TCr 5.25TCr 68TCr 5.24TCr 5.12TCr 2,16400Cr
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
-
Date Price Change
15/26/15 €160.50 +1.26%
14/26/14 €158.50 +3.56%
11/26/11 €153.05 +1.06%
10/26/10 €151.45 -2.04%
09/26/09 €154.60 +0.10%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
182.91USD
Average target price
195.67USD
Spread / Average Target
+6.97%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!